Cohance Lifesciences Limited CC-Sep23.pdf · 2023-11-09
I just had one question. So, from your opening remark, you cited that, spending heavily on a lot of commercial avenues. So, hiring a sales force in US, Europe, also be spending more on R&D for new platforms, etc. So, given that Suv en's margins are, already so high today, in the next three, one or two years, do we intend to go in an investment phase and, which may impact the margins and, it may get back these margins after a few years, or how do we see margins from maybe a one to two-year standpoint?
Right. So, in the near term, do we expect margins may come off slightly? Or do we intend to keep the current levels?